GORI, SUSANNA
 Distribuzione geografica
Continente #
NA - Nord America 45
EU - Europa 37
AS - Asia 21
AF - Africa 3
Totale 106
Nazione #
US - Stati Uniti d'America 45
IT - Italia 15
SG - Singapore 10
DE - Germania 8
IE - Irlanda 8
IN - India 7
GB - Regno Unito 4
JO - Giordania 3
CI - Costa d'Avorio 2
SE - Svezia 2
CN - Cina 1
TG - Togo 1
Totale 106
Città #
Dublin 8
Singapore 8
Bagnacavallo 6
Bologna 4
Princeton 4
Southend 4
Amman 3
Bentivoglio 3
Chandler 3
Fairfield 3
Abidjan 2
San Diego 2
Santa Clara 2
Turin 2
Ann Arbor 1
Berlin 1
Bühl 1
Cambridge 1
Des Moines 1
Houston 1
Hyderabad 1
Lomé 1
Redmond 1
Seattle 1
Wilmington 1
Totale 65
Nome #
Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) 49
Skip pattern approach toward the early access of innovative anticancer drugs 31
The neural basis of the Enigma illusion: A transcranial magnetic stimulation study 24
Erratum to ‘Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario’: [ESMO Open Volume 7, Issue 2, April 2022, 100406] 10
Totale 114
Categoria #
all - tutte 777
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 777


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202236 0 0 0 2 1 1 0 16 1 1 7 7
2022/202335 1 2 2 3 2 3 0 1 15 4 2 0
2023/202427 0 5 0 13 3 0 1 1 0 3 1 0
2024/202516 4 12 0 0 0 0 0 0 0 0 0 0
Totale 114